Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 4 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 648 Thoracic 198 Genitourinary 155 Lymphoid 113 Breast 99 Head & Neck 82 Gynecologic 60 Sarcoma 58 Tumor-Agnostic 30 Other solid neoplasm 28 Other hematologic neoplasm 14 CNS 13 Dermatologic 10 Plasma cell 8 Myeloid 4 Endocrine 1 Classical hematology 1

Conditions

Interventions

Cyclophosphamide 79 fludarabine phosphate 75 Busulfan 53 Whole-Body Irradiation 51 Mycophenolic Acid 50 Cyclosporine 47 Peripheral Blood Stem Cell Transplantation 46 fludarabine 42 Antilymphocyte Serum 37 Melphalan 36 Tacrolimus 35 Filgrastim 30 Cord Blood Stem Cell Transplantation 27 Radiotherapy 23 Methotrexate 22 Cytarabine 22 Methylprednisolone 19 Granulocyte Colony-Stimulating Factor 18 apixaban 17 Thiotepa 17 Dalteparin 13 thymoglobulin 12 Rivaroxaban 12 Alemtuzumab 12 eltrombopag 11 ferric carboxymaltose 10 Surveys and Questionnaires 10 Etoposide 10 Epoetin Alfa 10 Cyclosporins 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gemcitabine × Classical hematology × Clear all

NCT06018883 2025-08-07

PTCA199-3

Fudan University

Phase 3 Active not recruiting

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡